Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Pockets $1.6M SBIR Grant to Develop RNA-Amplification Technology

NEW YORK, Aug. 23 - Ambion today said it has won a $1.6 million Phase II SBIR grant from the US National Institutes of Health to continue developing its RNA-amplification technology.


Ambion, of Austin, Texas, said it hopes its technology will enhance the enzymatic processes to improve DNA microarray results and ultimately help researchers advance DNA arrays by integrating them onto both robotic and microfluidic platforms.


Click here for more information.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.